cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner
Open Access
- 17 April 2014
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 123 (16) , 2562-2572
Abstract
Key Points: cIAPs and XIAP negatively regulate cytokine production, including TNF to disrupt myeloid lineage differentiation. IAPs prevent RIPK1 and RIPK3 activity to limit cytokine production prior to cell death.Keywords
This publication has 50 references indexed in Scilit:
- cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activationCell Death & Differentiation, 2012
- Both cIAP1 and cIAP2 regulate TNFα-mediated NF-κB activationProceedings of the National Academy of Sciences, 2008
- cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 UbiquitinationMolecular Cell, 2008
- TNF-α Induces Two Distinct Caspase-8 Activation PathwaysCell, 2008
- A Smac Mimetic Rescue Screen Reveals Roles for Inhibitor of Apoptosis Proteins in Tumor Necrosis Factor-α SignalingCancer Research, 2007
- IAP Antagonists Target cIAP1 to Induce TNFα-Dependent ApoptosisCell, 2007
- IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent ApoptosisCell, 2007
- Autocrine TNFα Signaling Renders Human Cancer Cells Susceptible to Smac-Mimetic-Induced ApoptosisCancer Cell, 2007
- The Human Anti-apoptotic Proteins cIAP1 and cIAP2 Bind but Do Not Inhibit CaspasesJournal of Biological Chemistry, 2006
- X-linked IAP is a direct inhibitor of cell-death proteasesNature, 1997